Back to trial details

Intake questionnaire

AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

Applying to Allegheny Health Network · Pittsburgh, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Mesial Temporal Lobe Epilepsy?
3. Are you able to travel to Pittsburgh for study visits?